A cross-sectional study of erythromelalgia in patients with pachyonychia congenita

Br J Dermatol. 2024 Jul 16;191(2):300-302. doi: 10.1093/bjd/ljae143.

Rebecca L McCarthy^{1

2}, Janice Schwartz³, Jaimie Oldham², Christine Bodemer⁴, Celine Greco^{5

6}, Alain Hovnanian⁷, C David Hansen^{3

8}, Edel A O'Toole^{1

2}

¹ Centre for Cell Biology and Cutaneous Research, Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, UK.
² Department of Dermatology, Royal London Hospital, Barts Health NHS Trust, London, UK.
³ Pachyonychia Congenita Project, Salt Lake City, UT, USA.
⁴ Reference Center for Genodermatoses (MAGEC), Department of Dermatology, APHP, Hôpital Necker-Enfants Malades, Paris, France.
⁵ Department of Pain and Palliative Care, Hôpital Necker-Enfants Malades, Paris, France.
⁶ ATIP/Avenir Team 'Targeted Pain Therapy and Drug Repurposing in Genetic Skin Diseases', U1163 INSERM, Imagine Institut, Paris, France.
⁷ INSERM UMR 1163, Université Paris Cité, Laboratory of Genetic Skin Diseases, Imagine Institute, Paris, France.
⁸ Department of Dermatology, University of Utah, Salt Lake City, UT, USA.

No abstract available

Publication types